Jennifer Norton

Jen Norton is Vice President, U.S. Oncology Value and Access. In this role, Jen leads value, access, and reimbursement strategies and execution, as well as patient support programs for the U.S. Oncology commercial business unit.

Prior to joining Amgen Jen was most recently Vice President, Market Access & Reimbursement at Biogen, where she oversaw all US pricing and access functions for their Multiple Sclerosis and Spinal Muscular Atrophy programs, as well as market preparation activities for Alzheimer’s therapies. Prior to Biogen, Jen was Senior Director of Pricing and Contract Administration at Vertex Pharmaceuticals, and Senior Director of Life Sciences Strategy at iMany.

Jen earned her bachelor’s degree in Business Administration from Northeastern University.